Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 11/20 | 0.60 |
| ▸ | CCKBR | P32239 | 8/20 | 0.60 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20376297 | 1.00 | KISS1R (0.60) | KISS1RCCKBRIL23R | |
| SCHEMBL18082491 | 1.00 | KISS1R (0.60) | KISS1RCCKBRIL23R | |
| SCHEMBL18084076 | 1.00 | KISS1R (0.60) | KISS1RCCKBRIL23R | |
| SCHEMBL19842010 | 1.00 | KISS1R (0.60) | KISS1RCCKBRIL23R | |
| SCHEMBL19842025 | 1.00 | KISS1R (0.60) | KISS1RCCKBRIL23R | |
| SCHEMBL18084072 | 1.00 | KISS1R (0.60) | KISS1RCCKBRIL23R | |
| SCHEMBL24565311 | 0.97 | KISS1R (0.57) | KISS1RCCKBRIL23R | |
| SCHEMBL19841998 | 0.96 | KISS1R (0.57) | KISS1RCCKBRIL23R | |
| SCHEMBL22375184 | 0.96 | KISS1R (0.57) | KISS1RCCKBRIL23R | |
| SCHEMBL24565213 | 0.96 | KISS1R (0.57) | KISS1RCCKBRIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11311637-B2 | Positron emitting radionuclide labeled peptides for human uPAR PET imaging | CURASIGHT A/S (DK) | 2022-04-26 | — | — | US | disclosed |
| US-20200268914-A1 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | CURASIGHT APS (DK) | 2020-08-27 | — | — | US | disclosed |
| US-20180193495-A1 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | CURASIGHT A/S (DK) | 2018-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311637-B2 | Positron emitting radionuclide labeled peptides for human uPAR PET imaging | PLAUR, PLAU, SERPINE1 | KISS1R 552/4885CCKBR 370/4885IL23R 292/4885 |
| US-20180193495-A1 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | PLAUR, PLAU, SERPINE1 | KISS1R 552/4885CCKBR 370/4885IL23R 292/4885 |
| US-20200268914-A1 | POSITRON EMITTING RADIONUCLIDE LABELED PEPTIDES FOR HUMAN UPAR PET IMAGING | PLAUR, PLAU, SERPINE1 | KISS1R 552/4885CCKBR 370/4885IL23R 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.